# Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms

> **NCT02823184** · — · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 148 (actual)

## Conditions studied

- Polycythemia Vera
- Essential Thrombocythemia

## Interventions

- **BIOLOGICAL:** RNA sample of total leukocytes before start of treatment

## Key facts

- **NCT ID:** NCT02823184
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-27
- **Primary completion:** 2019-04-27
- **Final completion:** 2019-04-27
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2020-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02823184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02823184, "Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02823184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*